Advanced Accelerator Applications SA (AAAP)

Currency in USD
81.63
0.00(0.00%)
Real-time Data·
Showing Advanced Accelerator Applications historical data. For real-time data please try another search
Day's Range
81.5082.05
52 wk Range
0.0082.05
Key Statistics
Prev. Close
81.63
Open
81.63
Day's Range
81.5-82.05
52 wk Range
0-0
Volume
-
Average Volume (3m)
332.64K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Advanced Accelerator Applications SA Company Profile

Advanced Accelerator Applications SA develops, produces, and commercializes molecular nuclear, diagnostic, and therapeutic medicine products. It offers oxodotreotides; dotatate injections; edotreotide solutions; flurochol; and gluscan for oncology, cardiology, and neurology. It also provides LysaKare, a solution for reduction of kidney radiation exposure during peptide-receptor radionuclide therapy; DOPAVIEW, an aromatic amino acid that accumulates rapidly in target tissues; CARDIOGEN, closed system used to produce rubidium chloride for intravenous use; NEUROLITE, a radiopharmaceutical preparation of technetium bicisate injection; LUMARK, a radiopharmaceutical precursor; and LEUKOKIT, a medical device for the separation and labelling of autologous leukocytes. Additionally, it offers theragnostic platform, which is based on radiolabeling a targeting molecule for a receptor expressed on a tumor cell that helps in diagnosis, monitoring, and staging. The company was incorporated in 2002 and is based in Saint-Genis-Pouilly, France. Advanced Accelerator Applications SA operates as a subsidiary of Novartis AG.

Employees
563

Earnings

Latest Release
Mar 22, 2018
EPS / Forecast
-- / -0.32
Revenue / Forecast
-- / 45.25M
EPS Revisions
Last 90 days

AAAP Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.